V. Damiano
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 14
- HER2/EGFR in Cancer Research 6
- Colorectal Cancer Treatments and Studies 6
-
- Myasthenia Gravis and Thymoma 5
- Co-authors
- Fortunato Ciardiello (21 shared papers)Giampaolo Tortora (21 shared papers)Roberto Bianco (10 shared papers)Angelo Raffaele Bianco (6 shared papers)Sabino De Placido (8 shared papers)Gabriella Fontanini (7 shared papers)John M. Mendelsohn (4 shared papers)R. Caputo (2 shared papers)
- Journals
- Annals of Oncology (5 papers)British Journal of Cancer (5 papers)European Journal of Cancer (2 papers)Journal of Thoracic Oncology (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
V. Damiano
34 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 81
- Oncology 666
- Pulmonary and Respiratory Medicine 513
- Cancer Research 161
- Molecular Biology 448
- Immunology and Allergy 31
Countries citing papers authored by V. Damiano
This map shows the geographic impact of V. Damiano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Damiano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Damiano more than expected).
Fields of papers citing papers by V. Damiano
This network shows the impact of papers produced by V. Damiano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Damiano. The network helps show where V. Damiano may publish in the future.
Co-authors
The 25 scholars most cited alongside V. Damiano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells. | 2000 | 335 |
| 2 | 1977 | 235 | |
| 3 | 2005 | 160 | |
| 4 | 1996 | 125 | |
| 5 | 2008 | 111 | |
| 6 | Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides. | 1996 | 56 |
| 7 | 2000 | 46 | |
| 8 | Oral antisense that targets protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis, and growth factor production. | 2000 | 44 |
| 9 | Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity. | 2001 | 43 |
| 10 | 2021 | 41 | |
| 11 | 2004 | 31 | |
| 12 | 2010 | 31 | |
| 13 | 2016 | 29 | |
| 14 | Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells. | 1995 | 21 |
| 15 | 2008 | 19 | |
| 16 | 2002 | 14 | |
| 17 | Overexpression of the RI alpha subunit of protein kinase A confers hypersensitivity to topoisomerase II inhibitors and 8-chloro-cyclic adenosine 3'5'-monophosphate in Chinese hamster ovary cells. | 1994 | 12 |
| 18 | 2010 | 12 | |
| 19 | 1998 | 8 | |
| 20 | Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. | 1995 | 4 |
About V. Damiano
V. Damiano is a scholar working on Oncology, Neurology, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 37 papers that have together received 1.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (6 papers), HER2/EGFR in Cancer Research (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Myasthenia Gravis and Thymoma (5 papers), Adrenal and Paraganglionic Tumors (4 papers), Gastric Cancer Management and Outcomes (3 papers), Pituitary Gland Disorders and Treatments (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (666 citations), Pulmonary and Respiratory Medicine (513 citations), Cancer Research (161 citations), Molecular Biology (448 citations) and Immunology and Allergy (31 citations). V. Damiano has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Fortunato Ciardiello, Giampaolo Tortora, Roberto Bianco, Angelo Raffaele Bianco, Sabino De Placido, Gabriella Fontanini, John M. Mendelsohn, R. Caputo, Barbara A. Sloan and Aaron Janoff. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, European Journal of Cancer, Journal of Thoracic Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.